Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124633612 | 12463361 | 2 | F | 20160622 | 20160614 | 20160702 | EXP | CA-MLMSERVICE-20160527-0295281-1 | CA-ACCORD-041412 | ACCORD | NGUYEN PV, SPINELLI C. PRESCRIBING CASCADE IN AN ELDERLY WOMAN. CANADIAN PHARMACISTS JOURNAL. 2016; 149(3): 122-124 | 71.00 | YR | E | F | Y | 68.40000 | KG | 20160702 | PH | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124633612 | 12463361 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Y | 202553 | 2.5 | MG | BID | ||||||||
| 124633612 | 12463361 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Y | 0 | 20 | MG | QD | ||||||||
| 124633612 | 12463361 | 3 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Y | 0 | 25 | MG | QD | ||||||||
| 124633612 | 12463361 | 4 | SS | FESOTERODINE | FESOTERODINE | 1 | Y | 0 | 4 | MG | QD | ||||||||
| 124633612 | 12463361 | 5 | SS | ANETHOLE | ANETHOLE | 1 | Y | 0 | 25 | MG | TID | ||||||||
| 124633612 | 12463361 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 124633612 | 12463361 | 7 | C | FENOFIBRATE. | FENOFIBRATE | 1 | 0 | ||||||||||||
| 124633612 | 12463361 | 8 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 124633612 | 12463361 | 9 | C | RABEPRAZOLE/RABEPRAZOLE SODIUM | 2 | 0 | |||||||||||||
| 124633612 | 12463361 | 10 | C | LEVOTHYROXINE/LEVOTHYROXINE SODIUM | 2 | 0 | |||||||||||||
| 124633612 | 12463361 | 11 | C | POTASSIUM CITRATE. | POTASSIUM CITRATE | 1 | 0 | ||||||||||||
| 124633612 | 12463361 | 12 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 124633612 | 12463361 | 13 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
| 124633612 | 12463361 | 14 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 124633612 | 12463361 | 15 | C | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | 0 | ||||||||||||
| 124633612 | 12463361 | 16 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 124633612 | 12463361 | 17 | C | BUPROPION/BUPROPION HYDROCHLORIDE | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124633612 | 12463361 | 1 | Hypertension |
| 124633612 | 12463361 | 2 | Oedema peripheral |
| 124633612 | 12463361 | 3 | Oedema peripheral |
| 124633612 | 12463361 | 4 | Hypertonic bladder |
| 124633612 | 12463361 | 5 | Dry mouth |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124633612 | 12463361 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124633612 | 12463361 | Balance disorder | |
| 124633612 | 12463361 | Dry mouth | |
| 124633612 | 12463361 | Fall | |
| 124633612 | 12463361 | Hypertonic bladder | |
| 124633612 | 12463361 | Multiple fractures | |
| 124633612 | 12463361 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |